{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:10:03Z","timestamp":1772017803379,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jneuroim.2023.578015","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T17:20:01Z","timestamp":1673284801000},"page":"578015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Iron metabolism in non-anemic myasthenia gravis patients: A cohort study"],"prefix":"10.1016","volume":"375","author":[{"given":"Ke","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li'an","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhou","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578015_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420935697","article-title":"C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis","volume":"13","author":"Aguirre","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12883-016-0756-3","article-title":"Response to treatment of myasthenia gravis according to clinical subtype","volume":"16","author":"Akaishi","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mus.25205","article-title":"Factors affecting outcome in myasthenia gravis","volume":"54","author":"Andersen","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2023.578015_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/00207454.2013.853664","article-title":"Prognostic factors and health-related quality of life in ocular Myasthenia Gravis (OMG)","volume":"124","author":"Ariatti","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.14309\/ajg.0000000000000492","article-title":"Serum transferrin is an independent predictor of mortality in severe alcoholic hepatitis","volume":"115","author":"Atkinson","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fmolb.2019.00116","article-title":"The role of iron regulation in immunometabolism and immune-related disease","volume":"6","author":"Cronin","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10072-019-03746-1","article-title":"Italian recommendations for the diagnosis and treatment of myasthenia gravis","volume":"40","author":"Evoli","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ene.13189","article-title":"Adequate tacrolimus concentration for myasthenia gravis treatment","volume":"24","author":"Kanai","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0055","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1515\/CCLM.2002.176","article-title":"Total iron binding capacity and transferrin concentration in the assessment of iron status","volume":"40","author":"Kasvosve","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0060","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0065","doi-asserted-by":"crossref","first-page":"1060204","DOI":"10.3389\/fneur.2022.1060204","article-title":"Iron metabolism patterns in non-anemic patients with myasthenia gravis: a cross-sectional and follow-up study","volume":"13","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221080520","article-title":"Factors affecting minimal manifestation status induction in myasthenia gravis","volume":"15","author":"Li","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0075","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1016\/j.clnu.2020.11.033","article-title":"Association between iron status and the risk of adverse outcomes in COVID-19","volume":"40","author":"Lv","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2010.03017.x","article-title":"Course and prognosis of myasthenia gravis: a systematic review","volume":"17","author":"Mao","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0085","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. J. Heart."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0090","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0095","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010574","article-title":"Patient-acceptable symptom states in myasthenia gravis","volume":"95","author":"Mendoza","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","volume":"60","author":"Muppidi","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2023.578015_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/nyas.13544","article-title":"Rationale for the clinical guidelines for myasthenia gravis in Japan","volume":"1413","author":"Murai","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0115","doi-asserted-by":"crossref","first-page":"e1382","DOI":"10.1212\/WNL.0000000000012604","article-title":"Patient-reported symptom severity in a nationwide myasthenia gravis cohort: cross-sectional analysis of the Swedish GEMG study","volume":"97","author":"Petersson","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1468-1331.2003.00678.x","article-title":"Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study","volume":"10","author":"Romi","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0130","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10072-021-05382-0","article-title":"Disease severity and response to treatment in Iranian patients with myasthenia gravis","volume":"43","author":"Sinaei","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0135","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.22108","article-title":"Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR\/log ferritin index","volume":"86","author":"Skikne","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100111","article-title":"Calprotectin as potential novel biomarker in myasthenia gravis","volume":"4","author":"Stascheit","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.jneuroim.2023.578015_bb0155","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T08:47:40Z","timestamp":1701679660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":31,"alternative-id":["S0165572823000012"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578015","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron metabolism in non-anemic myasthenia gravis patients: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578015"}}